Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net sales $ 66,136 $ 78,778 $ 140,833 $ 163,582
Cost of sales 61,775 70,940 129,321 147,060
Gross profit 4,361 7,838 11,512 16,522
Selling, general and administrative expense 7,043 7,663 14,814 16,558
Acquisition costs and other 6 20 135 348
Proxy contest costs 2,734 0 2,909 0
Earn-out adjustments (827) (418) (823) (401)
Asset impairments 6,079 0 6,079 0
Operating (loss) income (10,674) 573 (11,602) 17
Other expense (income)        
Interest expense 532 1,010 1,251 2,034
Change in fair value of interest rate swaps (4) 77 81 124
Other, net (2,129) (110) (1,303) (404)
Loss before income taxes (9,073) (404) (11,631) (1,737)
Income tax benefit (2,116) (142) (3,496) (548)
Net loss $ (6,957) $ (262) $ (8,135) $ (1,189)
Net loss per common share:        
Basic (in dollars per share) $ (0.77) $ (0.03) $ (0.90) $ (0.13)
Diluted (in dollars per share) $ (0.77) $ (0.03) $ (0.90) $ (0.13)
Weighted average shares outstanding:        
Basic (in shares) 9,058 8,974 9,066 8,951
Dilutive effect from stock options and grants (in shares) 0 0 0 0
Diluted (in shares) 9,058 8,974 9,066 8,951